Liquid biopsy testing in urological cancers: Focus on urine
Pasquale Pisapia(University of Naples Federico II), Felice Crocetto(University of Naples Federico II), Giancarlo Troncone(Federico II University Hospital), R Capoluongo(University of Naples Federico II), Francesco Pepe(Federico II University Hospital), Gianluca Russo(University of Naples Federico II), Francesco Del Giudice(Sapienza University of Rome), Matteo Ferro(Istituti di Ricovero e Cura a Carattere Scientifico), Mariano Coppola(University of Naples Federico II), Michele Musone(University of Naples Federico II), Antonio Madonna(University of Naples Federico II), Umberto Malapelle(Federico II University Hospital)
Cited by 20
Related Papers
Liquid Biopsy for Advanced NSCLC: A Consensus Statement From the International Association for the Study of Lung Cancer
|Journal of Thoracic Oncology|2021|642
Prospective Assessment of Vesical Imaging Reporting and Data System (VI-RADS) and Its Clinical Impact on the Management of High-risk Non–muscle-invasive Bladder Cancer Patients Candidate for Repeated Transurethral Resection
|European Urology|2019|212
Renal Cell Carcinoma as a Metabolic Disease: An Update on Main Pathways, Potential Biomarkers, and Therapeutic Targets
|International Journal of Molecular Sciences|2022|190
Diagnostic Performance of Vesical Imaging Reporting and Data System for the Prediction of Muscle-invasive Bladder Cancer: A Systematic Review and Meta-analysis
|European Urology Oncology|2020|173
Profile of the Roche cobas® EGFR mutation test v2 for non-small cell lung cancer
|Expert Review of Molecular Diagnostics|2017|171